Seelos Therapeutics Inc.’s stock SEEL tumbled 58% in premarket trade Wednesday, after the company reported promising results from a trial of a treatment for Acute Suicidal Ideation and Behavior (ASIB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback